Publikasi Scopus 2010 s/d 2022

5032

Authors_(Last_Name)

Aarnoutse R., Ruesen C., Burhan E., Crevel R.V., Ruslami R.

Author S Id

6603807383;55796408600;36058554600;6603956378;12141875700;

Title

Reply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response"

Year

2014

Source Title

Antimicrobial Agents and Chemotherapy

Volume

Issue

Art No

Page Start

629

Page End

630

Page Count

Cited By

Link

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891516259&doi=10.1128%2fAAC.01651-13&partnerID=40&md5=2fe45cdce99b5d24f606d70f7be2ad58

Affiliations

Radboud University Medical Centre, Department of Pharmacy, Nijmegen, Netherlands; Radboud University Medical Centre, Department of Internal Medicine, Nijmegen, Netherlands; University of Indonesia, Faculty of Medicine, Department of Pulmonology and Respiratory Medicine, Jakarta, Indonesia; University of Padjadjaran, Medical Faculty, Department of Pharmacology and Therapy, Bandung, Indonesia

Authors With Affiliations

Aarnoutse, R., Radboud University Medical Centre, Department of Pharmacy, Nijmegen, Netherlands; Ruesen, C., Radboud University Medical Centre, Department of Internal Medicine, Nijmegen, Netherlands; Burhan, E., University of Indonesia, Faculty of Medicine, Department of Pulmonology and Respiratory Medicine, Jakarta, Indonesia; Crevel, R.V., Radboud University Medical Centre, Department of Internal Medicine, Nijmegen, Netherlands; Ruslami, R., University of Padjadjaran, Medical Faculty, Department of Pharmacology and Therapy, Bandung, Indonesia

Abstract

[No abstract available]

Author Keywords

Index Keywords

isoniazid plus rifampicin; pyrazinamide; tuberculostatic agent; antibiotic sensitivity; area under the curve; drug blood level; drug response; human; letter; maximum plasma concentration; minimum inhibitory concentration; priority journal; Antitubercular Agents; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary

Funding Details

Funding Text 1

Funding Text 2

Funding Text 3

Publisher

Issn

00664804

Isbn

Pubmed Id

24363391

Document Type

Letter

Sjr Best Quartile

Sjr

2361

Sjr Rank

1034